Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?
Clin Cancer Res
.
1999 Sep;5(9):2286-8.
Authors
G B Mills
,
R Schmandt
,
D Gershenson
,
R C Bast
PMID:
10499594
No abstract available
Publication types
Comment
Editorial
MeSH terms
Female
Humans
Individuality
Nucleic Acid Hybridization
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / genetics*
Predictive Value of Tests